Medications are nutrition. That's essentially the rationale behind a couple of Big Pharma corporations' decision to give a failed Alzheimer's drug a second chance.
In short, Big Pharma wants to treat a disease even before it ever shows up. What's more, an unproven medicine, rather than nutrition, is being pushed as the most effective way to deal with Alzheimer's.
There's a better way to guard against Alzheimer's that doesn't cost billions of dollars, risk your health or drive up the cost of medications.
This is not alternative health conspiratorial conjecture. This has been officially recorded but barely reported. So here is a sampling of recorded disease breakouts among children who were vaccinated for that disease. Enforcing or increasing vaccine schedules does not really prevent disease; it only increases the chances of worse health or gravely critical adverse reactions, ranging from autistic spectrum disorders (ASD) to decreased immunity and increased poor health.
Plans to use an array of powerful air cannons in an undersea seismic study near a Central California nuclear power plant have federal and state officials juggling concerns over marine life with public safety.
The doctors prescribing the drugs don't know they don't do what they're meant to. Nor do their patients. The manufacturers know full well, but they're not telling.
U.S. military deaths in the Afghan war have reached 2,000, a cold reminder of the human cost of an 11-year-old conflict that garners little public interest at home as the United States prepares to withdraw most of its combat forces by the end of 2014.
Satirical website The Onion has completely owned an Iran news agency. The Iran news outlet published as true a story from The Onion saying rural white Americans would rather vote for President Mahmoud Ahmadinejad than Barack Obama.
Former U.N. Secretary-General Kofi Annan says former British Prime Minister Tony Blair could have averted the invasion of Iraq in 2003.
The U.S. Commodity Futures Trading Commission rule restraining speculation was rejected by a federal judge, handing a victory to two Wall Street groups that challenged the constraints.
Guantanamo prisoner Omar Khadr, the Toronto-born detainee whose decade-long case has bitterly divided Canadians, is on his way home to serve the remainder of his sentence. The Toronto Star has learned that the 26-year-old prisoner was flown off the U.S. Naval base on Cuba’s southeast shore and expected to arrive in Canada early Saturday morning.
